Press-release for stocks for novartis ag for GLAXF

| Email alert Add to watchlist
GSK | $40.5 -0.39% -0.03% 2.8M

| Email alert Add to watchlist
AMGN | $265.505 -0.66% -0.67% 1.7M

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
GLAXF | $20.07 -14.18% 1K

| Email alert Add to watchlist
SNYNF | $92.9 -2.18% 880

| Email alert Add to watchlist
BAX | $40.04 -0.72% -0.6% 3M

| Email alert Add to watchlist
AZN | $68.75 -0.26% -0.26% 7.6M

| Email alert Add to watchlist
SNY | $46.22 0.63% 0.63% 1.7M

| Email alert Add to watchlist
NVS | $94.41 0.95% 0.0% 1.4M

| Email alert Add to watchlist
ABBV | $161.67 -0.38% -0.04% 5.4M

| Email alert Add to watchlist
BMRN S | $91.51 -0.77% -0.78% 1.9M

| Email alert Add to watchlist
set therapeutics market

Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published: 2024-03-28 (Crawled : 15:30) - prnewswire.com
GLAXF | $20.07 -14.18% 1K

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | $94.41 0.95% 0.0% 1.4M

| -1.53% | O: 0.52% H: 0.0% C: 0.0%
JNJ | $147.59 0.05% 0.0% 8.5M

| -5.45% | O: 1.32% H: 0.0% C: 0.0%
GSK | $40.5 -0.39% -0.03% 2.8M

| -5.79% | O: 0.02% H: 0.51% C: -0.3%
LLY | $750.77 -0.12% 0.0% 2.3M

| -3.52% | O: 0.28% H: 1.71% C: -0.3%
BMY | $48.51 0.48% 0.0% 12M

| -8.9% | O: 0.26% H: 2.03% C: 1.57%
AMGN | $265.505 -0.66% -0.67% 1.7M

| -7.26% | O: 0.54% H: 0.0% C: 0.0%
antibody research global

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.07 -14.18% 1K

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | $92.9 -2.18% 880

| -6.75% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | $138.88 -4.19% 960

| 0.92% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | $93.6375 6.88% 82K

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | $94.41 0.95% 0.0% 1.4M

| -1.53% | O: 0.52% H: 0.0% C: 0.0%
GSK | $40.5 -0.39% -0.03% 2.8M

| -5.79% | O: 0.02% H: 0.51% C: -0.3%
BMY | $48.51 0.48% 0.0% 12M

| -8.9% | O: 0.26% H: 2.03% C: 1.57%
ABBV | $161.67 -0.38% -0.04% 5.4M

| -10.36% | O: 0.36% H: 0.72% C: 0.61%
ABT | $108.89 -0.2% 0.04% 4.6M

| -2.83% | O: 1.04% H: 0.0% C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M

| -5.73% | O: -0.96% H: 0.0% C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M

| 0.69% | O: -0.12% H: 0.25% C: -0.63%
AMGN | $265.505 -0.66% -0.67% 1.7M

| -7.26% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

Urinary Tract Infection Treatment Market Projected to Reach US$ 10.73 Billion by 2030: Telemedicine Integration Revolutionizes UTI Care, Self-Care Products Gain Momentum
Published: 2024-02-29 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.07 -14.18% 1K

| -3.76% | O: -2.33% H: 3.68% C: 2.44%
NVSEF | $93.6375 6.88% 82K

| -7.38% | O: 0.89% H: 0.0% C: 0.0%
NVS | $94.41 0.95% 0.0% 1.4M

| -6.5% | O: 1.03% H: 0.14% C: 0.05%
JNJ | $147.59 0.05% 0.0% 8.5M

| -8.55% | O: 0.28% H: 0.0% C: 0.0%
GSK | $40.5 -0.39% -0.03% 2.8M

| -3.34% | O: 0.26% H: 0.18% C: 0.05%
BMY | $48.51 0.48% 0.0% 12M

| -4.41% | O: 0.37% H: 0.27% C: -0.1%
integration reach momentum infection treatment market

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.07 -14.18% 1K

| -5.87% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | $92.9 -2.18% 880

| -2.86% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | $138.88 -4.19% 960

| 7.04% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | $93.6375 6.88% 82K

| -8.14% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $63.874 -4.38% 11K

| 23.77% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | $9.55 -1.11% 300K

| -16.62% | O: -0.27% H: 0.0% C: -1.17%
TAK | $13.18 -1.42% 0.0% 1.8M

| -10.58% | O: -0.2% H: 0.14% C: -0.48%
NVS | $94.41 0.95% 0.0% 1.4M

| -7.95% | O: -0.06% H: 0.46% C: 0.29%
GSK | $40.5 -0.39% -0.03% 2.8M

| -3.43% | O: -0.69% H: 1.42% C: 1.22%
LLY | $750.77 -0.12% 0.0% 2.3M

| 0.65% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.51 0.48% 0.0% 12M

| -4.71% | O: -0.65% H: 1.63% C: 1.48%
ABBV | $161.67 -0.38% -0.04% 5.4M

| -8.31% | O: -0.88% H: 1.46% C: 1.13%
SNY | $46.22 0.63% 0.63% 1.7M

| -0.55% | O: 1.67% H: 0.0% C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M

| 5.59% | O: -2.81% H: 2.08% C: 1.38%
AMGN | $265.505 -0.66% -0.67% 1.7M

| -6.33% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $196.76 -0.72% -0.72% 1.2M

| Email alert Add to watchlist
VTRS | $11.32 -0.09% -0.09% 4.4M

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
AZN | $68.75 -0.26% -0.26% 7.6M

| Email alert Add to watchlist
GLAXF | $20.07 -14.18% 1K

| Email alert Add to watchlist
GSK | $40.5 -0.39% -0.03% 2.8M

| Email alert Add to watchlist
AZNCF | $138.88 -4.19% 960

| Email alert Add to watchlist
JAZZ | $110.9 0.29% 0.29% 580K

| Email alert Add to watchlist
NVS | $94.41 0.95% 0.0% 1.4M

| Email alert Add to watchlist
AMGN | $265.505 -0.66% -0.67% 1.7M

| Email alert Add to watchlist
cancer cell global growth market

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.07 -14.18% 1K

| -1.6% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | $138.88 -4.19% 960

| 12.66% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | $9.55 -1.11% 300K

| -14.31% | O: 0.37% H: 0.74% C: 0.28%
TAK | $13.18 -1.42% 0.0% 1.8M

| -7.9% | O: 0.14% H: 0.35% C: 0.07%
NVS | $94.41 0.95% 0.0% 1.4M

| -6.09% | O: -0.34% H: 0.23% C: -1.13%
JNJ | $147.59 0.05% 0.0% 8.5M

| -5.76% | O: 0.7% H: 0.0% C: 0.0%
GSK | $40.5 -0.39% -0.03% 2.8M

| -1.39% | O: 1.22% H: 0.07% C: -0.43%
LLY | $750.77 -0.12% 0.0% 2.3M

| 1.83% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.51 0.48% 0.0% 12M

| -2.49% | O: -0.18% H: 0.48% C: -1.91%
ABBV | $161.67 -0.38% -0.04% 5.4M

| -6.59% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $14.185 -0.87% -0.88% 630K

| -22.02% | O: -1.15% H: 1.03% C: -1.5%
VRTX | $397.48 0.24% 0.23% 1.4M

| -5.06% | O: -0.28% H: 0.49% C: -0.32%
SNY | $46.22 0.63% 0.63% 1.7M

| 1.45% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.48 3.88% 8.1K

| -6.2% | O: -3.1% H: 1.2% C: -0.8%
INCY | $53.42 -0.8% -0.8% 1.6M

| -7.62% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $196.76 -0.72% -0.72% 1.2M

| -19.59% | O: -3.72% H: 0.58% C: -3.82%
AZN | $68.75 -0.26% -0.26% 7.6M

| 11.92% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $376.41 -0.43% -0.43% 190K

| -3.4% | O: -2.3% H: 1.65% C: 0.83%
AMGN | $265.505 -0.66% -0.67% 1.7M

| -9.82% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ | $0.0003 -50.0% 24K

| 157.14% | O: -14.29% H: 16.67% C: 0.0%
GLAXF | $20.07 -14.18% 1K

| -3.02% | O: 0.82% H: 0.0% C: 0.0%
SNYNF | $92.9 -2.18% 880

| -0.76% | O: -1.64% H: 0.0% C: 0.0%
VTRS | $11.32 -0.09% -0.09% 4.4M

| -3.58% | O: -0.34% H: 0.0% C: -1.2%
NVS | $94.41 0.95% 0.0% 1.4M

| -8.75% | O: -1.57% H: 0.26% C: -0.47%
GSK | $40.5 -0.39% -0.03% 2.8M

| -3.62% | O: -0.48% H: 0.16% C: 0.0%
BAX | $40.04 -0.72% -0.6% 3M

| 1.68% | O: -0.96% H: 5.91% C: 3.74%
ABT | $108.89 -0.2% 0.04% 4.6M

| -4.88% | O: -1.41% H: 0.0% C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M

| -0.59% | O: -2.25% H: 0.0% C: 0.0%
AMGN | $265.505 -0.66% -0.67% 1.7M

| -10.26% | O: 0.38% H: 0.34% C: -0.72%
america growth market

Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | $138.88 -4.19% 960

| 1.57% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
NVS | $94.41 0.95% 0.0% 1.4M

| -8.99% | O: 0.09% H: 0.39% C: -0.36%
GSK | $40.5 -0.39% -0.03% 2.8M

| -2.99% | O: 0.43% H: 0.67% C: 0.21%
BAX | $40.04 -0.72% -0.6% 3M

| 0.83% | O: 0.21% H: 0.24% C: -1.04%
ABBV | $161.67 -0.38% -0.04% 5.4M

| -5.47% | O: 1.48% H: 0.0% C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M

| 0.73% | O: 1.33% H: 0.0% C: 0.0%
BMRN S | $91.51 -0.77% -0.78% 1.9M

| 1.9% | O: -0.38% H: 1.79% C: 0.22%
AZN | $68.75 -0.26% -0.26% 7.6M

| 2.52% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $265.505 -0.66% -0.67% 1.7M

| -16.0% | O: -0.18% H: 0.0% C: -6.22%
america therapeutics growth market

Vertigo Drugs Market Research Report 2023 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2018-2028F
Published: 2024-02-01 (Crawled : 18:00) - prnewswire.com
ENDPQ | $0.0003 -50.0% 24K

| 200.0% | O: -83.33% H: 500.0% C: 500.0%
GLAXF | $20.07 -14.18% 1K

| 1.0% | O: -0.7% H: 0.0% C: 0.0%
NVS | $94.41 0.95% 0.0% 1.4M

| -10.37% | O: -0.5% H: 0.26% C: -1.03%
GSK | $40.5 -0.39% -0.03% 2.8M

| -0.32% | O: -0.05% H: 0.59% C: 0.27%
report research global market

Global Sustained Release Coatings Markets, 2018-2022 and 2023-2028: Growing Demand for Controlled Drug Delivery Boosts Expansion
Published: 2024-02-01 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.07 -14.18% 1K

| -1.68% | O: -1.29% H: 0.0% C: -1.38%
PFE A | $25.91 0.19% -0.04% 34M

| -4.32% | O: 0.07% H: 0.83% C: 0.7%
NVS | $94.41 0.95% 0.0% 1.4M

| -8.76% | O: 1.55% H: 0.79% C: 0.25%
GSK | $40.5 -0.39% -0.03% 2.8M

| 2.69% | O: 1.27% H: 1.87% C: 1.73%
EMN | $97.32 -0.67% 0.0% 1.4M

Process Industries

| 16.48% | O: 0.79% H: 0.8% C: 0.77%
drug expansion global growing

Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published: 2024-01-30 (Crawled : 23:00) - prnewswire.com
ALPMF | $9.48 43.47% 1.7K

| -17.92% | O: 4.34% H: 0.0% C: 0.0%
GLAXF | $20.07 -14.18% 1K

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $138.88 -4.19% 960

| 3.57% | O: 3.41% H: 0.0% C: -2.45%
ALPMY | $9.55 -1.11% 300K

| -19.87% | O: 0.0% H: 1.38% C: 0.26%
VTRS | $11.32 -0.09% -0.09% 4.4M

| -4.15% | O: -0.08% H: 3.47% C: -0.25%
NVS | $94.41 0.95% 0.0% 1.4M

| -12.38% | O: -2.04% H: 0.19% C: -1.97%
GSK | $40.5 -0.39% -0.03% 2.8M

| 3.61% | O: 4.04% H: 1.57% C: -3.02%
ABBV | $161.67 -0.38% -0.04% 5.4M

| -1.97% | O: 0.5% H: 0.07% C: -0.81%
SNY | $46.22 0.63% 0.63% 1.7M

| -6.76% | O: 1.75% H: 0.0% C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M

| 2.28% | O: 0.82% H: 0.12% C: -1.64%
market

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.07 -14.18% 1K

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $138.88 -4.19% 960

| 3.57% | O: 3.41% H: 0.0% C: -2.45%
VTRS | $11.32 -0.09% -0.09% 4.4M

| -4.15% | O: -0.08% H: 3.47% C: -0.25%
NVS | $94.41 0.95% 0.0% 1.4M

| -12.38% | O: -2.04% H: 0.19% C: -1.97%
GSK | $40.5 -0.39% -0.03% 2.8M

| 3.61% | O: 4.04% H: 1.57% C: -3.02%
ABBV | $161.67 -0.38% -0.04% 5.4M

| -1.97% | O: 0.5% H: 0.07% C: -0.81%
SNY | $46.22 0.63% 0.63% 1.7M

| -6.76% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $5.35 1.52% 1.5% 270K

| 12.28% | O: -0.1% H: 2.31% C: -1.26%
AZN | $68.75 -0.26% -0.26% 7.6M

| 2.28% | O: 0.82% H: 0.12% C: -1.64%
AMGN | $265.505 -0.66% -0.67% 1.7M

| -15.61% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published: 2024-01-29 (Crawled : 18:00) - prnewswire.com
ALPMF | $9.48 43.47% 1.7K

| -16.48% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | $20.07 -14.18% 1K

| 6.51% | O: 2.93% H: 0.0% C: -1.15%
ALPMY | $9.55 -1.11% 300K

| -20.07% | O: -3.53% H: 3.49% C: 3.4%
NVS | $94.41 0.95% 0.0% 1.4M

| -12.54% | O: -0.59% H: 0.49% C: 0.41%
GSK | $40.5 -0.39% -0.03% 2.8M

| 3.69% | O: 0.26% H: 0.13% C: -0.18%
ABBV | $161.67 -0.38% -0.04% 5.4M

| -1.37% | O: 0.19% H: 0.46% C: 0.43%
SNY | $46.22 0.63% 0.63% 1.7M

| -6.65% | O: 0.12% H: 0.0% C: 0.0%
kidney renal expected million therapeutics growth market

Antibacterial Drugs Market Report 2024-2034, Featuring Profiles of AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer & Sanofi
Published: 2024-01-26 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.07 -14.18% 1K

| 2.46% | O: -1.67% H: 0.0% C: 0.0%
SNYNF | $92.9 -2.18% 880

| -6.33% | O: 1.8% H: 0.0% C: -1.82%
NVS | $94.41 0.95% 0.0% 1.4M

| -11.76% | O: 0.29% H: 0.15% C: -0.13%
JNJ | $147.59 0.05% 0.0% 8.5M

| -7.23% | O: 0.8% H: 0.0% C: 0.0%
GSK | $40.5 -0.39% -0.03% 2.8M

| 4.27% | O: 1.36% H: 0.23% C: -0.76%
BMY | $48.51 0.48% 0.0% 12M

| -2.22% | O: 0.71% H: 0.48% C: -0.52%
ABBV | $161.67 -0.38% -0.04% 5.4M

| -1.37% | O: 0.85% H: 0.0% C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M

| -6.07% | O: 0.5% H: 0.0% C: 0.0%
report antibacterial sanofi market

Obsessive-Compulsive Disorder Drugs Market size worth USD 348.54 million, 55% Growth to Originate from North America - Technavio
Published: 2024-01-25 (Crawled : 06:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

| -14.09% | O: -3.67% H: 0.0% C: 0.0%
NVS | $94.41 0.95% 0.0% 1.4M

| -12.22% | O: -0.44% H: 0.19% C: -0.08%
GSK | $40.5 -0.39% -0.03% 2.8M

| 3.77% | O: -0.23% H: 0.03% C: -0.26%
JAZZ | $110.9 0.29% 0.29% 580K

| -9.93% | O: 0.28% H: 0.36% C: -0.53%
BWAY | $5.22 1.36% 1.34% 34K

| -13.75% | O: 1.47% H: 0.65% C: -1.45%
america growth market

Over-The-Counter Drug Market to Grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB as Key Market Contributors - 17000+ Technavio Reports
Published: 2024-01-24 (Crawled : 05:00) - prnewswire.com
RBGPF | $51.618 6.46% 160K

Consumer Non-Durables

| -27.29% | O: -1.75% H: 0.0% C: 0.0%
SNYNF | $92.9 -2.18% 880

| -9.83% | O: -3.01% H: 0.69% C: -0.75%
AZNCF | $138.88 -4.19% 960

| 0.77% | O: -0.42% H: 0.0% C: -1.8%
RBGLY | $10.6 -2.05% 4.8M

| -25.97% | O: -0.35% H: 0.07% C: -0.14%
NVS | $94.41 0.95% 0.0% 1.4M

| -12.36% | O: 0.22% H: 0.43% C: -0.39%
GSK | $40.5 -0.39% -0.03% 2.8M

| 3.11% | O: 0.48% H: 0.66% C: -1.11%
ABT | $108.89 -0.2% 0.04% 4.6M

| -5.19% | O: -3.45% H: 0.0% C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M

| -6.41% | O: 0.92% H: 0.0% C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M

| 2.97% | O: -0.03% H: 0.29% C: -0.19%
drug astrazeneca key therapeutics market

Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio
Published: 2024-01-23 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.07 -14.18% 1K

| 0.5% | O: -2.34% H: 0.43% C: 0.43%
AZNCF | $138.88 -4.19% 960

| -0.25% | O: -2.16% H: 1.17% C: 1.17%
NVSEF | $93.6375 6.88% 82K

| -13.7% | O: 0.46% H: 0.0% C: 0.0%
VTRS | $11.32 -0.09% -0.09% 4.4M

| -2.75% | O: 0.17% H: 1.33% C: 0.94%
NVS | $94.41 0.95% 0.0% 1.4M

| -12.96% | O: -0.96% H: 0.3% C: 0.28%
GSK | $40.5 -0.39% -0.03% 2.8M

| 2.45% | O: -0.76% H: 0.38% C: 0.13%
ABBV | $161.67 -0.38% -0.04% 5.4M

| -1.51% | O: 0.37% H: 0.0% C: 0.0%
ABT | $108.89 -0.2% 0.04% 4.6M

| -5.26% | O: -0.07% H: 0.0% C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M

| -8.33% | O: -2.05% H: 0.0% C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M

| 2.37% | O: -1.27% H: 0.8% C: 0.69%
drug hospital infection therapeutics growth market

Antimicrobial Therapeutics Market to grow by USD 51.4 billion from 2022 to 2027, North America accounts for 38% of market growth- Technavio
Published: 2024-01-17 (Crawled : 06:00) - prnewswire.com
CSLLY | $91.51 3.3% 18K

| -4.43% | O: -0.64% H: 0.54% C: 0.54%
GLAXF | $20.07 -14.18% 1K

| 3.11% | O: -0.56% H: 0.0% C: 0.0%
SNYNF | $92.9 -2.18% 880

| -10.52% | O: -1.83% H: 0.0% C: 0.0%
ALPMY | $9.55 -1.11% 300K

| -23.38% | O: -1.74% H: 0.0% C: -1.35%
NVS | $94.41 0.95% 0.0% 1.4M

| -12.33% | O: 0.49% H: 0.18% C: 0.04%
GSK | $40.5 -0.39% -0.03% 2.8M

| 1.55% | O: -0.08% H: 0.1% C: -0.18%
ABBV | $161.67 -0.38% -0.04% 5.4M

| -0.2% | O: -0.15% H: 0.74% C: 0.18%
SNY | $46.22 0.63% 0.63% 1.7M

| -9.29% | O: 0.45% H: 0.06% C: -0.5%
america therapeutics market

Osteoarthritis Therapeutics Market to grow by USD 3.96 billion from 2022-2027, North America to account for 32% of market growth - Technavio
Published: 2024-01-17 (Crawled : 05:00) - prnewswire.com
GLAXF | $20.07 -14.18% 1K

| 3.11% | O: -0.56% H: 0.0% C: 0.0%
SNYNF | $92.9 -2.18% 880

| -10.52% | O: -1.83% H: 0.0% C: 0.0%
VTRS | $11.32 -0.09% -0.09% 4.4M

| -3.66% | O: -1.02% H: 0.95% C: -1.46%
NVS | $94.41 0.95% 0.0% 1.4M

| -12.33% | O: 0.49% H: 0.18% C: 0.04%
GSK | $40.5 -0.39% -0.03% 2.8M

| 1.55% | O: -0.08% H: 0.1% C: -0.18%
ABT | $108.89 -0.2% 0.04% 4.6M

| -4.04% | O: 0.12% H: 0.77% C: 0.27%
SNY | $46.22 0.63% 0.63% 1.7M

| -9.29% | O: 0.45% H: 0.06% C: -0.5%
ANIK | $25.35 1.4% 1.38% 37K

| 15.31% | O: -1.05% H: 3.55% C: 3.31%
america osteoarthritis therapeutics growth market

← Previous
1
2
3
4
5
6
7
8
9
…
13
14
Next →

Gainers vs Losers

49%

51%

Top 10 Gainers

KAVL | $6.275 135.02% 57.45% 44M

Wholesale Trade

PXMD | $0.7375 79.09% 44.16% 4.5M

DYNT | $0.371 -5.12% 43.09% 3.3M

LGVN P | $2.94 73.96% 42.52% 57M

HUBC | $1.94 49.23% 32.99% 73M

SPCB | $0.4044 46.52% 31.75% 130M

Electronic Technology

ONVO | $1.34 32.66% 24.62% 54M

Professional, Scientific, and T...

OMQS | $0.6869 32.1% 24.3% 3.6M

SNPO | $10.555 29.67% 22.88% 4M

AMBI | $3.72 -26.77% 21.77% 9.8K